Herpesvirus 6 (HHV-6) Antibody, IgM
Human herpesvirus-6 (HHV-6), a beta-herpes virus, is most often isolated in patients with the childhood disease exanthem subitum (Roseola infantum), but it is also implicated in various central nervous system diseases such as encephalitis and multiple sclerosis, as well as myocarditis. Other disorders seen with HHV-6 infection are post-viral chronic fatigue syndrome, hepatitis, and various cancers. HHV-6 infection typically occurs during early infancy, leaving few adults still susceptible to primary infection. The virus lays dormant after resolution of the first infection, and unless immunocompromised, will not appear symptomatically. When immunocompromised, HHV-6 can lead to serious consequences. In transplant patients it can cause graft rejection. Similar to HIV/AIDS, reactivation of HHV-6 can cause organ damage or organ death.
HHV-6 has been subclassed into HHV-6A and HHV-6B. Studies have shown that HHV-6A has been associated with immunocompromised patients and HHV-6B causes exanthema subitum (roseola infantum). Antibodies to HHV-6 typically appear early in the infection and remain at low titer after resolution. Detection of HHV-6 IgG is usually diagnostic of a current or past infection with HHV-6.
- Diagnosis of diseases associated with HHV-6 infection
- Screening for pre-emptive therapy in immunocompromised patients infected with HHV- 6
Positive in:
- Patient with acute infection
- Patient with persistent infection
- Patient with past infection
Result interpretation:
Negative: No detectable IgG antibody. No evidence of recent or past exposure. If specific IgG antibodies are not detected and a recent infection is suspected, this can be confirmed by retesting 7-14 days later.
Equivocal: Equivocal samples should be re-tested. Samples that remain equivocal after repeat testing should be repeated by an alternative method or another sample should be collected.
Positive: Presence of detectable IgG antibody suggests recent or past exposure to HHV-6.
<0.9 Index value or Negative
0.91 - 1.1 Index value or Equivocal
>1.1 Index value or Positive
Serum (SST) or Plasma EDTA (Lavender), Heparin (Green), cerebrospinal fluid collected in a sterile container or tube.
- Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- J Med Virol. 2010 Sep;82(9):1560-8. Review. [PMID: 20648610]
- Clin Microbiol Rev. 1997 Jul;10(3):521-67. [PMID: 9227865]
- Lancet. 1988 May 14;1(8594):1065-7. [PMID: 2896909]
- Annu Rev Med. 1993;44:377-83. [PMID: 8386499]
- Emerg Infect Dis. 1999 May-Jun;5(3):353-66. [PMID: 10341172]
- Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).
- Human-Herpesvirus 6, Molecular Detection, PCR, Plasma, Interpretive Handbook 2007-2008. Rochester: MN (2009).